We reported previously that daily injections of isophane insulin prevented both hyperglycemia and insulitis in nonobese diabetic (NOD) mice (Atkinson, M., N. Maclaren; and R. Luchetta. 1990. Diabetes. 39:933-937). The possible mechanisms responsible include reduced immunogenicity of pancreatic beta-cells from "beta-cell rest" and induced active immunoregulation to insulin (Aaen, IK., J. Rygaard, K. Josefsen, H. Petersen, C. H. Brogren, T. Horn, and K. Buschard. 1990. Diabetes. 39:697-701). We report here that intermittent immunizations with insulin or its metabolically inactive B-chain in incomplete Freund's adjuvant also prevent diabetes in NOD mice, whereas immunizations with A-chain insulin or with BSA do not. Adoptive transfer of splenocytes from B-chain insulin-immunized mice prevented diabetes in recipients co-infused with diabetogenic spleen cells, an effect that was abolished by prior in vivo elimination of either CD4+ or CD8+ cells. Insulin immunization did not reduce the extent of intraislet inflammation (insulitis); however, it did abolish expression of IFN-gamma mRNA within the insulitis lesions. Immunizations with insulin thus induce an active suppressive response to determinants on the B-chain that converts the insulitis lesion from one that is destructive to one that is protective.
A Muir, A Peck, M Clare-Salzler, Y H Song, J Cornelius, R Luchetta, J Krischer, N Maclaren
Title and authors | Publication | Year |
---|---|---|
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
C Zheng, W Xuan, Z Chen, R Zhang, X Huang, Y Zhu, S Ma, K Chen, L Chen, M He, H Lin, W Liao, J Bin, Y Liao |
Frontiers in pharmacology | 2022 |
Interferon Family Cytokines in Obesity and Insulin Sensitivity.
Huang LY, Chiu CJ, Hsing CH, Hsu YH |
Cells | 2022 |
100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention
A Ziegler, T Danne, C Daniel, E Bonifacio |
The American Journal of Medicine | 2021 |
Auto-antigen and Immunomodulatory Agent–Based Approaches for Antigen-Specific Tolerance in NOD Mice
EJ Bassin, JD Piganelli, SR Little |
Current Diabetes Reports | 2021 |
Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice
J Lo, CQ Xia, R Peng, MJ Clare-Salzler |
Journal of Immunology Research | 2018 |
Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice
J Grönholm, PP Pagni, MN Pham, CB Gibson, PF Macomber, JL Vela, M Herrath, MJ Lenardo |
Diabetologia | 2017 |
Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?
M Knip |
Diabetologia | 2017 |
Analysis of antigen specific T cells in diabetes – Lessons from pre-clinical studies and early clinical trials
B Krishnamurthy, C Selck, J Chee, G Jhala, TW Kay |
Journal of Autoimmunity | 2016 |
Regenerative Medicine - from Protocol to Patient
LC Zelarayán, MP Zafiriou, WH Zimmermann |
Regenerative Medicine - from Protocol to Patient | 2016 |
Thinking bedside at the bench: the NOD mouse model of T1DM
JC Reed, KC Herold |
Nature Reviews Endocrinology | 2015 |
The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance
W Hao, CJ Greenbaum, JP Krischer, D Cuthbertson, JB Marks, JP Palmer |
Diabetes care | 2015 |
MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice
L Zhang, P Londono, L Yu, S Grimes, P Blackburn, P Gottlieb, GS Eisenbarth |
Autoimmunity | 2014 |
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes
L Zhang, F Crawford, L Yu, A Michels, M Nakayama, HW Davidson, JW Kappler, GS Eisenbarth |
Proceedings of the National Academy of Sciences | 2014 |
ZnT8-Reactive T Cells Are Weakly Pathogenic in NOD Mice but Can Participate in Diabetes Under Inflammatory Conditions
DK Nayak, B Calderon, AN Vomund, ER Unanue |
Diabetes | 2014 |
IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse: Autoimmune diabetes induction in RIP-CD80GP mice
YF Fuchs, K Adler, A Lindner, A Karasinsky, C Wilhelm, M Weigelt, H Balke, K Förtsch, LF Mortler-Hildebrandt, DM Harlan, K Pechhold, AG Ziegler, E Bonifacio |
Clinical & Experimental Immunology | 2014 |
Antigen Presentation in the Autoimmune Diabetes of the NOD Mouse
ER Unanue |
Annual Review of Immunology | 2014 |
The cytokine production of peripheral blood mononuclear cells reflects the autoantibody profile of patients suffering from type 1 diabetes
J Labikova, J Vcelakova, T Ulmannova, L Petruzelkova, S Kolouskova, K Stechova |
Cytokine | 2014 |
Inducing immune tolerance: a focus on Type 1 diabetes mellitus
D Xu, S Prasad, SD Miller |
Diabetes Management | 2013 |
B7-H4.Ig inhibits the development of Type 1 diabetes by regulating Th17 cells in NOD mice
IF Lee, X Wang, J Hao, N Akhoundsadegh, L Chen, L Liu, S Langermann, D Ou, GL Warnock |
Cellular Immunology | 2013 |
Islet autoantigens: structure, function, localization, and regulation
P Arvan, M Pietropaolo, D Ostrov, CJ Rhodes |
Cold Spring Harbor Perspectives in Medicine | 2012 |
Antigen-Specific Therapeutic Approaches in Type 1 Diabetes
X Clemente-Casares, S Tsai, C Huang, P Santamaria |
Cold Spring Harbor Perspectives in Medicine | 2012 |
Regenerative Medicine
S Ricco, L Boone, JF Peroni |
Equine Surgery | 2012 |
Short-term subcutaneous insulin treatment delays but does not prevent diabetes in NOD mice: Immunomodulation
V Brezar, S Culina, MC Gagnerault, R Mallone |
European Journal of Immunology | 2012 |
MECHANISMS IN ENDOCRINOLOGY: Insulin and type 1 diabetes: immune connections
S Culina, V Brezar, R Mallone |
European Journal of Endocrinology | 2012 |
Animal Models in Diabetes Research
HG Joost, H Al-Hasani, A Schürmann |
2012 | |
Beyond the Hormone: Insulin as an Autoimmune Target in Type 1 Diabetes
V Brezar, JC Carel, C Boitard, R Mallone |
Endocrine reviews | 2011 |
Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes
MC Johnson, B Wang, R Tisch |
Human vaccines | 2011 |
Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?
B Phillips, M Trucco, N Giannoukakis |
Clinical and Developmental Immunology | 2011 |
GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes
C Skoglund, M Chéramy, R Casas, J Ludvigsson, CS Hampe |
Pediatric Diabetes | 2011 |
Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice
L Zhang, BD Stadinski, A Michels, JW Kappler, GS Eisenbarth |
Diabetes/Metabolism Research and Reviews | 2011 |
Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes
SA Hinke |
Drug Development Research | 2011 |
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick |
Williams Textbook of Endocrinology | 2011 |
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
TL van Belle, KT Coppieters, MG von Herrath |
Physiological reviews | 2011 |
Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?
L Chatenoud |
Nature Reviews Endocrinology | 2010 |
Molecular Targeting of Islet Autoantigens
B Stadinski, J Kappler, GS Eisenbarth |
Immunity | 2010 |
Early induction of GAD65-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD65
S Axelsson, M Hjorth, L Åkerman, J Ludvigsson, R Casas |
Diabetes/Metabolism Research and Reviews | 2010 |
Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice
T Arai, H Moriyama, M Shimizu, H Sasaki, M Kishi, Y Okumachi, H Yasuda, K Hara, K Yokono, M Nagata |
Clinical Immunology | 2010 |
Textbook of Diabetes: Holt/Textbook of Diabetes
HE Larsson, AJ Delli, SA Ivarsson, Å Lernmark |
Textbook of Diabetes: Holt/Textbook of Diabetes | 2010 |
Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
D Bresson, M Herrath |
Diabetes care | 2009 |
Transgenically Induced GAD Tolerance Curtails the Development of Early -Cell Autoreactivities but Causes the Subsequent Development of Supernormal Autoreactivities to Other -Cell Antigens
J Tian, H Dang, H Boehmer, E Jaeckel, DL Kaufman |
Diabetes | 2009 |
DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes
RR Santos, A Sartori, DS Lima, PR Souza, AA Coelho-Castelo, VL Bonato, CL Silva |
Journal of immune based therapies and vaccines | 2009 |
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients
E Vandemeulebroucke, FK Gorus, K Decochez, I Weets, B Keymeulen, CD Block, J Tits, DG Pipeleers, C Mathieu |
Diabetes & Metabolism | 2009 |
Parameters influencing antigen-specific immunotherapy for Type 1 diabetes
B Wang, R Tisch |
Immunologic Research | 2008 |
Parameters influencing antigen-specific immunotherapy for Type 1 diabetes
B Wang, R Tisch |
Immunologic Research | 2008 |
The Type and Frequency of Immunoregulatory CD4+ T-Cells Govern the Efficacy of Antigen-Specific Immunotherapy in Nonobese Diabetic Mice
SM Pop, CP Wong, Q He, Y Wang, MA Wallet, KS Goudy, R Tisch |
Diabetes | 2007 |
Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetes
T Staeva-Vieira, M Peakman, M Herrath |
Clinical & Experimental Immunology | 2007 |
Selected Mechanistic Studies and Future Directions for Thymoglobulin
M Ruzek, J Dzuris, L Gao, R Bigelow, J Waire, A Scaria, S Nahill, J Williams |
Transplantation | 2007 |
Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit–insulin B chain fusion protein vaccine produced in silkworm
Z Gong, Y Jin, Y Zhang |
Vaccine | 2007 |
Dominant CTL-inducing epitopes on GAD65 are adjacent to or overlap with dominant Th-inducing epitopes
RY Busick, C Aguilera, A Quinn |
Clinical Immunology | 2007 |
Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice
H Moriyama, M Nagata, T Arai, Y Okumachi, K Yamada, R Kotani, H Yasuda, K Hara, K Yokono |
Diabetes Research and Clinical Practice | 2007 |
Type 1 Diabetes in Adults: Principles and Practice
J Cropsey, M Fineman |
Type 1 Diabetes in Adults: Principles and Practice | 2007 |
Étiologie et physiopathologie du diabète de type 1
D Dubois-Laforgue |
EMC - Endocrinologie - Nutrition | 2007 |
Immunological Responses to Exogenous Insulin
SE Fineberg, TT Kawabata, D Finco-Kent, RJ Fountaine, GL Finch, AS Krasner |
Endocrine reviews | 2007 |
Immune Regulation and Immunotherapy in Autoimmune Disease
J Zhang |
2007 | |
Tissue inhibitor of metalloproteinase-2 inhibits T-cell infiltration and preserves pancreatic β-cell function in an in vitro type 1 diabetes mellitus model
CC Woods, K Sundar, C Tessler, TW Lebsack, L Grainger, A Nielsen, D Bleich, D DeLuca |
Journal of Autoimmunity | 2006 |
The Autoimmune Diseases
I Kang, J Craft |
The Autoimmune Diseases | 2006 |
Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes
SM Pop, CP Wong, DA Culton, SH Clarke, R Tisch |
Journal of Experimental Medicine | 2005 |
Nutrition and Disease Prevention
K Imaizumi |
Soy in Health and Disease Prevention | 2005 |
A Comprehensive Review of Interventions in the NOD Mouse and Implications for Translation
LK Shoda, DL Young, S Ramanujan, CC Whiting, MA Atkinson, JA Bluestone, GS Eisenbarth, D Mathis, AA Rossini, SE Campbell, R Kahn, HT Kreuwel |
Immunity | 2005 |
Interferon-γ-induced regulation of the pancreatic derived cytokine FAM3B in islets and insulin-secreting βTC3 cells
W Xu, Z Gao, J Wu, BA Wolf |
Molecular and Cellular Endocrinology | 2005 |
Immune modulation for prevention of type 1 diabetes mellitus
I Raz, R Eldor, Y Naparstek |
Trends in Biotechnology | 2005 |
Antigen-Specific Induction of Regulatory T Cells for Type 1 Diabetes Therapy
C Filippi, D Bresson, M Herrath |
International Reviews of Immunology | 2005 |
Innovative Immune-Based Therapeutic Approaches for the Treatment of Type 1 Diabetes Mellitus
R Eldor, IR Cohen, I Raz |
International Reviews of Immunology | 2005 |
T cell targeted immunotherapy for autoimmune disease
E Lee, AA Sinha |
Autoimmunity | 2005 |
Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4 + CD25 + regulatory T cells during autoimmune diabetes
SM Pop, CP Wong, DA Culton, SH Clarke, R Tisch |
Journal of Experimental Medicine | 2005 |
Regulatory T Cells in Inflammation
LS Taams, MH Wauben, AN Akbar |
2005 | |
Antigen-Based Therapies Using Ignored Determinants of β Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice
AP Olcott, J Tian, V Walker, H Dang, B Middleton, L Adorini, L Washburn, DL Kaufman |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
Expression of preproinsulin-2 gene shapes the immune response to preproinsulin in normal mice
B Faideau, JP Briand, C Lotton, I Tardivel, P Halbout, J Jami, JF Elliott, P Krief, S Muller, C Boitard, JC Carel |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading
PA Ott, MT Dittrich, BA Herzog, R Guerkov, PA Gottlieb, AL Putnam, I Durinovic-Bello, BO Boehm, M Tary-Lehmann, PV Lehmann |
Journal of Clinical Immunology | 2004 |
DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice
A Gauvrit, M Debailleul, AT Vu, P Sai, JM Bach |
Clinical & Experimental Immunology | 2004 |
Regulatory T cells and type 1 diabetes
D Homann, M Herrath |
Clinical Immunology | 2004 |
Regulatory T-cells in type 1 diabetes
AE Juedes, MG von Herrath |
Diabetes/Metabolism Research and Reviews | 2004 |
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes
E Jaeckel, MA Lipes, H Boehmer |
Nature Immunology | 2004 |
Molecular Pathways Altered by Insulin B9-23 Immunization
SE Eckenrode, QG Ruan, CD Collins, P Yang, RA Mcindoe, A Muir, JX She |
Annals of the New York Academy of Sciences | 2004 |
Oral Insulin Therapy to Prevent Progression of Immune-Mediated (Type 1) Diabetes
B Ergun-Longmire, J Marker, A Zeidler, R Rapaport, P Raskin, B Bode, D Schatz, A Vargas, D Rogers, S Schwartz, J Malone, J Krischer, NK Maclaren |
Annals of the New York Academy of Sciences | 2004 |
Specific antigen vaccination to treat autoimmune disease
H McDevitt |
Proceedings of the National Academy of Sciences | 2004 |
Characteristics of testicular lesions in mice infected with a low dose of encephalomyocarditis (EMC) virus
A Yamanouchiueno, Y Nakayama, K Doi |
Experimental and Molecular Pathology | 2004 |
Autoimmune diabetes: More than just one flavor?
HK Chiu, JP Palmer |
Journal of Endocrinological Investigation | 2004 |
Effects of Tacrolimus (FK506) on Encephalomyocarditic Virus-Induced Diabetes in Mice
S Yama, W Nishioka, Y Hirokami, R Setoguchi, N Takeyama, K Saeki, Y Matsumoto, T Hayashi, K Doi, T Onodera |
Microbiology and Immunology | 2004 |
Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient non obese diabetic mice
Karine Thébault-Baumont, Danielle Dubois-Laforgue, Patricia Krief, Jean-Paul Briand, Philippe Halbout, Karine Vallon-Geoffroy, Joëlle Morin, Véronique Laloux, Agnès Lehuen, Jean-Claude Carel, Jacques Jami, Sylviane Muller, Christian Boitard |
Journal of Clinical Investigation | 2003 |
Latent autoimmune diabetes in adults (LADA)
Ramachandra G Naik, Jerry P Palmer |
Reviews in Endocrine and Metabolic Disorders | 2003 |
Th1 and Th2 Pancreatic Inflammation Differentially Affects Homing of Islet-Reactive CD4 Cells in Nonobese Diabetic Mice
NJ Hill, KV Gunst, N Sarvetnick |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
More Stringent Conditions of Plasmid DNA Vaccination Are Required to Protect Grafted Versus Endogenous Islets in Nonobese Diabetic Mice
C Seifarth, S Pop, B Liu, CP Wong, R Tisch |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse
K Koczwara, M Schenker, S Schmid, K Kredel, AG Ziegler, E Bonifacio |
Clinical Immunology | 2003 |
Absence of the T-bet Gene Coding for the Th1-Related Transcription Factor Does Not Affect Diabetes-Associated Phenotypes in Balb/c Mice
E Melanitou, E Liu, D Miao, L Yu, LH Glimcher, G Eisenbarth |
Annals of the New York Academy of Sciences | 2003 |
Cytokines and Chemokines in Autoimmune Disease
P Santamaria |
2003 | |
Systemic Administration of IL-18 Promotes Diabetes Development in Young Nonobese Diabetic Mice
Y Oikawa, A Shimada, A Kasuga, J Morimoto, T Osaki, H Tahara, T Miyazaki, F Tashiro, E Yamato, J Miyazaki, T Saruta |
Journal of immunology (Baltimore, Md. : 1950) | 2003 |
Insulin-Specific Tolerance in Diabetes
PA Gottlieb, GS Eisenbarth |
Clinical Immunology | 2002 |
Immunomodulatory vaccination in autoimmune disease
I Urbanek-Ruiz, PJ Ruiz, L Steinman, CG Fathman |
Endocrinology & Metabolism Clinics of North America | 2002 |
Environmental factors in the etiology of type 1 diabetes
HK �kerblom, O Vaarala, H Hy�ty, J Ilonen, M Knip |
American Journal of Medical Genetics | 2002 |
Immunotherapy of insulin-dependent diabetes mellitus
EL Masteller, JA Bluestone |
Current Opinion in Immunology | 2002 |
CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer
KV Tarbell, M Lee, E Ranheim, CC Chao, M Sanna, SK Kim, P Dickie, L Teyton, M Davis, H McDevitt |
Journal of Experimental Medicine | 2002 |
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide
H Moriyama, L Wen, N Abiru, E Liu, L Yu, D Miao, R Gianani, FS Wong, GS Eisenbarth |
Proceedings of the National Academy of Sciences | 2002 |
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases
JF Bach |
Arthritis research | 2002 |
Antigen-based immunotherapy drives the precocious development of autoimmunity
J Tian, AP Olcott, DL Kaufman |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide
David G Alleva, Amitabh Gaur, Liping Jin, Dale Wegmann, Peter A Gottlieb, Anil Pahuja, Eric B Johnson, Theresa Motheral, Amy Putnam, Paul D Crowe, Nicholas Ling, Stefen A Boehme, Paul J Conlon |
Diabetes | 2002 |
NKT cell defects in NOD mice suggest therapeutic opportunities
Anjli Kukreja, Guilia Costi, John Marker, Chen Hui Zhang, Sunil Sinha, Zhong Sun, Noel Maclaren |
Journal of Autoimmunity | 2002 |
T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse
P Halbout, JP Briand, C Bécourt, S Muller, C Boitard |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
A disease-associated cellular immune response in type I diabetics to an immunodominant epitope of insulin
David G. Alleva, Paul D. Crowe, Liping Jin, William W. Kwok, Nicholas Ling, Michael Gottschalk, Paul J. Conlon, Peter A. Gottlieb, Amy L. Putnam, Amitabh Gaur |
Journal of Clinical Investigation | 2001 |
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes
W Chen, I Bergerot, JF Elliott, LC Harrison, N Abiru, GS Eisenbarth, TL Delovitch |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Plasmid DNAs Encoding Insulin and Glutamic Acid Decarboxylase 65 Have Distinct Effects on the Progression of Autoimmune Diabetes in Nonobese Diabetic Mice
DJ Weaver, B Liu, R Tisch |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
TOLERANCE TOISLETAUTOANTIGENS INTYPE1 DIABETES
JF Bach, L Chatenoud |
Annual Review of Immunology | 2001 |
Prospects for predicting and stopping the development of type 1 of diabetes
FK Gorus, DG Pipeleers, BD Registry |
Best Practice & Research Clinical Endocrinology & Metabolism | 2001 |
Immunization with DNA Encoding an Immunodominant Peptide of Insulin Prevents Diabetes in NOD Mice
I Urbanek-Ruiz, PJ Ruiz, V Paragas, H Garren, L Steinman, CG Fathman |
Clinical Immunology | 2001 |
New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies
C Thivolet |
Clinical Endocrinology | 2001 |
Diabetes Vaccines: A Future to be Realized
K Lin-Su, A Kukreja, NK MacLaren |
Diabetes Technology & Therapeutics | 2001 |
Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus
M Abel, M Krokowski |
BioDrugs | 2001 |
Peptide and major histocompatibility complex-specific breaking of humoral tolerance to native insulin with the B9-23 peptide in diabetes-prone and normal mice
N Abiru, AK Maniatis, L Yu, D Miao, H Moriyama, D Wegmann, GS Eisenbarth |
Diabetes | 2001 |
Pancreatic stem cells: building blocks for a better surrogate islet to treat type 1 diabetes
AB Peck, M Chaudhari, JG Cornelius, VK Ramiya |
Annals of Medicine | 2001 |
Tacrolimus, but not Cyclosporine A, significantly increases expression of ICAM-1 and IFN-? in the NOD mouse
G Papaccio, MV Latronico, A Graziano, A Lanza, M Pedull |
Journal of Cellular Biochemistry | 2001 |
Antigen-Specific Mediated Suppression of β Cell Autoimmunity by Plasmid DNA Vaccination
R Tisch, B Wang, DJ Weaver, B Liu, T Bui, J Arthos, DV Serreze |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
A Glutamic Acid Decarboxylase 65-Specific Th2 Cell Clone Immunoregulates Autoimmune Diabetes in Nonobese Diabetic Mice
R Tisch, B Wang, MA Atkinson, DV Serreze, R Friedline |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Therapeutic Alteration of Insulin-Dependent Diabetes Mellitus Progression by T Cell Tolerance to Glutamic Acid Decarboxylase 65 Peptides In Vitro and In Vivo
SS Wilson, TC White, D DeLuca |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Does GAD Have a Unique Role in Triggering IDDM?
S Baekkeskov, J Kanaani, JC Jaume, S Kash |
Journal of Autoimmunity | 2000 |
Analysis of Cytokine mRNA Expression in Pancreatic Islets of Nonobese Diabetic Mice
H Hirai, Y Kaino, T Ito, K Kida |
Journal of Pediatric Endocrinology and Metabolism | 2000 |
Endogenous Ecotropic Murine Leukemia Viral (MuLV) Envelope Protein as a New Autoantigen Reactive with Non-obese Diabetic Mice Sera
SE Choi, KS Kim, KH Kim, UY Choi, HM Kim, JW Yoon, Y Kang |
Journal of Autoimmunity | 2000 |
Prevention of Autoimmune Diabetes by Oral Administration of Syngeneic Pancreatic Extract to Young NOD Mice
S Reddy, N Stefanovic, M Karanam |
Pancreas | 2000 |
Dual Overlapping Peptides Recognized by Insulin Peptide B:9–23 T Cell Receptor AV13S3 T Cell Clones of the NOD Mouse
N Abiru, D Wegmann, E Kawasaki, P Gottlieb, E Simone, GS Eisenbarth |
Journal of Autoimmunity | 2000 |
The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis
JN Francis, AG Lamont, SJ Thompson |
Immunology | 2000 |
Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity
T Kunikata, T Tatefuji, H Aga, K Iwaki, M Ikeda, M Kurimoto |
European Journal of Pharmacology | 2000 |
Prevention of Type 1 Diabetes: Is Now the Time?1
DJ Becker, RE LaPorte, I Libman, M Pietropaolo, HM Dosch |
The Journal of clinical endocrinology and metabolism | 2000 |
Multiple Genes/Multiple Autoantigens Role in Type 1 Diabetes
N Abiru, GS Eisenbarth |
Clinical Reviews in Allergy & Immunology | 2000 |
Immunotherapy of Immune-Mediated Diabetes: Present and Future
N Maclaren |
Clinical Reviews in Allergy & Immunology | 2000 |
New Concepts of the Etiopathogenesis and Treatment of Insulin-Dependent Diabetes Mellitus
JF Bach |
Clinical Reviews in Allergy & Immunology | 2000 |
NKT Cell Cytokine Imbalance in Murine Diabetes Mellitus
AB Frey, TD Rao |
Autoimmunity | 1999 |
Detection of dendritic cells in the non-obese diabetic (NOD) mouse islet pancreas infiltrate is correlated with Th2-cytokine production
G Papaccio, AD Luca, BD Luca, FA Pisanti, S Zarrilli |
Journal of Cellular Biochemistry | 1999 |
Immunogenetics of insulin-dependent diabetes mellitus
K Kida, Y Kaino, T Ito, H Hirai, K Nakamura |
Acta Paediatrica | 1999 |
Autoreactive CD4+ T Cells Protect from Autoimmune Diabetes via Bystander Suppression Using the IL-4/Stat6 Pathway
D Homann, A Holz, A Bot, B Coon, T Wolfe, J Petersen, TP Dyrberg, MJ Grusby, MG von Herrath |
Immunity | 1999 |
An Alternative Perspective to the Immune Response in Autoimmune Exocrinopathy: Induction of Functional Quiescence Rather Than Destructive Autoaggression
MG Humphreys-Beher, J Brayer, S Yamachika, AB Peck, R Jonsson |
Scandinavian Journal of Immunology | 1999 |
Human insulin B chain but not A chain decreases the rate of diabetes in BB rats
HY Song, MM Abad, CP Mahoney, RC McEvoy |
Diabetes Research and Clinical Practice | 1999 |
New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model
MG Humphreys-Beher, AB Peck |
Archives of Oral Biology | 1999 |
The use of islet autoantibody markers in the prediction of autoimmune type 1 diabetes
WE Winter |
Clinical Immunology Newsletter | 1999 |
Antigen-based immunotherapy for autoimmune disease: from animal models to humans?
J Tian, A Olcott, L Hanssen, D Zekzer, DL Kaufman |
Immunology Today | 1999 |
The Decade of Autoimmunity
BD Stollar |
The Decade of Autoimmunity | 1999 |
Molecular and Cellular Pediatric Endocrinology
S Handwerger |
1999 | |
Autoimmune Endocrinopathies
R Volpé |
1999 | |
T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes
D Dubois-LaForgue, J C Carel, P F Bougnères, J G Guillet, C Boitard |
Journal of Clinical Immunology | 1999 |
Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice
H Yasuda, M Nagata, K Arisawa, R Yoshida, K Fujihira, N Okamoto, H Moriyama, M Miki, I Saito, H Hamada, K Yokono, M Kasuga |
Journal of Clinical Investigation | 1998 |
Are there unique autoantigens triggering autoimmune diseases?
JF Bach, S Koutouzov, PM Endert |
Immunological Reviews | 1998 |
Th1 unresponsiveness can be infectious for unrelated antigens
B Charlton, CG Fathman, RM Slattery |
Immunology and Cell Biology | 1998 |
Prevention of Diabetes in Non-Obese Diabetic (NOD) Mice by Short-Term and High-Dose IGF-I Treatment
Y Kaino, H Hirai, T Ito, K Kida |
Journal of Pediatric Endocrinology and Metabolism | 1998 |
Antigen-based T-cell-targeted immunotherapy: recent developments in autoimmunity and allergy
C Stemmer, G Guichard |
Expert Opinion on Therapeutic Patents | 1998 |
Recombinant Adenovirus Encoding gp100 Modulates Experimental Melanin-Protein Induced Uveitis (EMIU)
CC Chan, Y Li, B Sun, Q Li, DM Matteson, DF Shen, RB Nussenblatt, Y Zhai |
Journal of Autoimmunity | 1998 |
Protection from Insulin Dependent Diabetes Mellitus Afforded by Insulin Antigens in Incomplete Freund's Adjuvant Depends on Route of Administration
P Hutchings, A Cooke |
Journal of Autoimmunity | 1998 |
PREVENTION OF TYPE 1 DIABETES
A Rabinovitch, JS Skyler |
Medical Clinics of North America | 1998 |
Cytokines and Their Roles in Pancreatic Islet β-Cell Destruction and Insulin-Dependent Diabetes Mellitus
A Rabinovitch, WL Suarez-Pinzon |
Biochemical Pharmacology | 1998 |
Administration of IL-4 Prevents Autoimmune Diabetes but Enhances Pancreatic Insulitis in NOD Mice
Y Tominaga, M Nagata, H Yasuda, N Okamoto, K Arisawa, H Moriyama, M Miki, K Yokono, M Kasuga |
Clinical Immunology and Immunopathology | 1998 |
Interferon-α and interferon-γ differentially affect pancreatic β-cell phenotype and function
ME Baldeón, T Chun, HR Gaskins |
American journal of physiology. Cell physiology | 1998 |
Endocrine Autoimmunity and Associated Conditions
AP Weetman |
1998 | |
Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice
DG Karounos, JS Bryson, DA Cohen |
Journal of Clinical Investigation | 1997 |
Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 Cytokines
M Polanski, NS Melican, J Zhang, HL Weiner |
Journal of Autoimmunity | 1997 |
Effect of Oral and Intravenous Insulin and Glutamic Acid Decarboxylase in NOD Mice
VK Ramiya, XZ Shang, CH Wasserfall, NK Maclaren |
Autoimmunity | 1997 |
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
TL Delovitch, B Singh |
Immunity | 1997 |
Immunization Therapies in the Prevention of Diabetes
VK Ramiya, MS Lan, CH Wasserfall, AL Notkins, NK Maclaren |
Journal of Autoimmunity | 1997 |
Insulin Therapy of Prediabetes Suppresses TH1 Associated Gene Expression in BB Rat Pancreas
H Kolba, U Wörz-Pagenstert, R Kleemann, H Rothe, P Rowsell, S Rastegar, FW Scott |
Autoimmunity | 1997 |
T cell receptor restriction of diabetogenic autoimmune NOD T cells
E Simone, D Daniel, N Schloot, P Gottlieb, S Babu, E Kawasaki, D Wegmann, GS Eisenbarth |
Proceedings of the National Academy of Sciences | 1997 |
Insulin-dependent diabetes mellitus: the hypothesis of molecular mimicry between islet cell antigens and microorganisms
NK Maclaren, MA Atkinson |
Molecular Medicine Today | 1997 |
T Cell Recognition of Human Pre-Proinsulin Peptides Depends on the Polymorphism at HLA DQ Locus: A Study Using HLA DQ8 and DQ6 Transgenic Mice
R Raju, SR Munn, CS David |
Human Immunology | 1997 |
Systemic antigen in the treatment of T-cell-mediated autoimmune diseases
R Liblau, R Tisch, N Bercovici, HO McDevitt |
Immunology Today | 1997 |
Role of T-cell anergy and suppression in susceptibility to IDDM
I Bergerot, G Arreaza, M Cameron, H Chou, TL Delovitch |
Research in Immunology | 1997 |
Tolerance and Uveitis
JF Bach |
American Journal of Ophthalmology | 1997 |
Autoimmune Diabetes
DV House, WE Winter |
Clinics in Laboratory Medicine | 1997 |
COMBINATION THERAPY WITH CYCLOSPORINE AND INTERLEUKIN-4 OR INTERLEUKIN-10 PROLONGS SURVIVAL OF SYNGENEIC PANCREATIC ISLET GRAFTS IN NONOBESE DIABETIC MICE: Islet Graft Survival Does Not Correlate with mRNA Levels of Type 1 or Type 2 Cytokines, or Transforming Growth Factor-?? in the Islet Grafts1
A Rabinovitch, WL Suarez-Pinzon, O Sorensen, RV Rajotte, RF Power |
Transplantation | 1997 |
Clinical Pathology of Pancreatic Disorders
JA Lott |
1997 | |
Prevention of Type I Diabetes and Recurrent β-Cell Destruction of Transplanted Islets*
RH Slover, GS Eisenbarth |
Endocrine reviews | 1997 |
Pharmacological Approaches to the Prevention of Autoimmune Diabetes:
WE Winter, DV House, D Schatz |
Drugs | 1997 |
Le diabète sucré insulino-dépendant: une maladie auto-immune à laquelle participent des cellules T
R Tisch |
Annales de l'Institut Pasteur/Actualités | 1996 |
Prevention of Insulin-dependent Diabetes: Where Are We Now?
P Pozzilli |
Diabetes/Metabolism Reviews | 1996 |
The Physiological Role of Regulatory T Cells in the Prevention of Autoimmunity: the Function of the Thymus in the Generation of the Regulatory T Cell Subset
A Saoudi, B Seddon, V Heath, D Fowell, D Mason |
Immunological Reviews | 1996 |
Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice
J Tian, M Clere-Salzler, A Herschenfeld, B Middleton, D Newman, R Mueller, S Arita, C Evans, MA Atkinson, Y Mullen, N Sarvetnick, AJ Tobin, PV Lehmann, DL Kaufman |
Nature Medicine | 1996 |
Regulation of autoimmune diabetes: Characteristics of non-islet-antigen specific therapies
LS Gazda, AG Baxter, KJ Lafferty |
Immunology and Cell Biology | 1996 |
Insulin-like growth factor I (IGF-I) delays the onset of diabetes in non-obese diabetic (NOD) mice
Y Kaino |
Diabetes Research and Clinical Practice | 1996 |
Intranasal Administration of Insulin Peptide B: 9-23 Protects NOD Mice from Diabetes
D Daniel, DR Wegmann |
Annals of the New York Academy of Sciences | 1996 |
Immunotherapies in diabetes
VK Ramiya, NK Maclaren |
Trends in Endocrinology & Metabolism | 1996 |
New Strategies in Oral Immunotherapy for Diabetes Prevention
A Muir, V Ramiya |
Diabetes/Metabolism Reviews | 1996 |
Viruses, cytokines, antigens, and autoimmunity
R Gianani, N Sarvetnick |
Proceedings of the National Academy of Sciences | 1996 |
Strategies for preventing type I diabetes mellitus
CF Verge, GS Eisenbarth |
The Western journal of medicine | 1996 |
Checkpoints in the progression of autoimmune disease: lessons from diabetes models
I André, A Gonzalez, B Wang, J Katz, C Benoist, D Mathis |
Proceedings of the National Academy of Sciences | 1996 |
The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
A Saoudi, B Seddon, D Fowell, D Mason |
Journal of Experimental Medicine | 1996 |
The nature of autoantigens targeted in autoimmune endocrine diseases
YH Song, Y Li, NK Maclaren |
Immunology Today | 1996 |
Lessons from Animal Diabetes VI
E Shafrir |
1996 | |
Insulin-dependent diabetes mellitus as a ?-cell targeted disease of immunoregulation
JF Bach |
Journal of Autoimmunity | 1995 |
Glutamic acid decarboxylase and other autoantigens in IDDM
GT Nepom |
Current Opinion in Immunology | 1995 |
The Th1/Th2 balance in autoimmunity
B Charlton, KJ Lafferty |
Current Opinion in Immunology | 1995 |
Isohormonal therapy of endocrine autoimmunity
N Schloot, GS Eisenbarth |
Immunology Today | 1995 |
Genetic analysis of type 1 diabetes using whole genome approaches
JA Todd |
Proceedings of the National Academy of Sciences | 1995 |
Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes
LC Harrison |
Molecular Medicine | 1995 |
Nutrition and Immunology
DM Klurfeld |
1993 | |
Insulin-dependent diabetes mellitus
JF Bach |
Current Opinion in Immunology | 1991 |